In this episode, Dr. Sofie Derijcke (AZ Groeninge, Kortrijk) discusses the key results of the UNICORN study, assessing osimertinib in advanced non-small cell lung cancer (NSCLC) patients with uncommon activating EGFR mutations (Dutch).
Top
